MEROPENEM VENUS PHARMA 1 g, powder for solution for injection/for infusion 10 bottles
Active ingredients: Meropenem, Meropenem trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection or infusion10 bottlesintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MEROPENEM VENUS PHARMA 1 g, poudre pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre (type II) de 1349 mg
- Marketing authorisation holder
- VENUS PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60902083CIP73025901CIP133400930259016Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉROPÉNEM TRIHYDRATÉpoudre | — | SA |
| MÉROPÉNEM ANHYDREpoudre | 1 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.